During the last financial year, PSO’s subsidiary, Cerisma (Pvt.) Limited, made steady progress towards achieving operational ...

Pakistan State Oil (PSO) has proactively optimized its operations in response to the evolving geopolitical environment, to ensure that the nation's energy needs are met with precision and reliability.

Alumis is preparing to file its oral TYK2 inhibitor envudeucitinib as a treatment for psoriasis later this year, after a pair of positive phase 3 trials. The South San Francisco biotech said ...

The City of Tulsa is currently assessing conditions following severe weather and a potential tornado that moved through North Tulsa Friday evening.

Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...

Key Summary The transition from psoriasis to psoriatic arthritis (PsA) is driven by several modifiable risk factors, ...

A man is dead and three others, including a Pasco County deputy are in the hospital, following several shootings in New Port ...

Cosentyx is the only IL-17A inhibitor approved for this population, and the first differentiated mechanism in nearly a ...

Pediatric patients with moderate to severe hidradenitits suppurativa may now receive secukinumab following new FDA approval for those aged 12 and up.

A representative of OMCs said that the companies were making profits till crude price was hovering around USD78 a barrel. The ...

ORKA-001 EVERLAST-A 16-week data now expected in 2Q 2026 following rapid enrollment, with longer-term follow-up data expected in 2H 2026 ORCA-SURGE Phase 2 trial of ORKA-002 in psoriasis initiated ...